Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/oramed-letter-to-shareholders-302183192.html
https://www.prnewswire.com/news-releases/oramed-pharmaceuticals-inc-announces-the-buy-back-of-its-common-stock-302183179.html
https://www.prnewswire.com/news-releases/oramed-signs-term-sheet-with-htit-to-create-a-joint-venture-to-advance-oral-drug-delivery-technology-globally-301891452.html
https://www.prnewswire.com/news-releases/oramed-to-present-at-novel-therapies-for-type-2-diabetes--obesity-summit-301828322.html
https://www.prnewswire.com/news-releases/oramed-announces-that-its-chinese-partner-htit-has-successfully-completed-a-phase-3-oral-insulin-clinical-trial-and-submitted-a-marketing-authorization-application-in-china-301824604.html
https://endpts.com/oramed-to-review-strategic-alternatives-clouding-path-forward-for-oral-insulin/
https://www.prnewswire.com/news-releases/oramed-pharmaceuticals-issues-shareholder-update-301742999.html
https://www.fiercebiotech.com/biotech/orameds-oral-insulin-flunks-phase-3-diabetes-test-sending-stock-down-70
https://www.prnewswire.com/news-releases/oramed-granted-us-combination-therapy-patent-for-oral-glp-1--insulin-for-the-treatment-of-diabetes-301713190.html